Boai NKY Medical Holdings Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Boai NKY Medical Holdings heeft een totaal eigen vermogen van CN¥3.5B en een totale schuld van CN¥405.4M, wat de schuld-eigenvermogensverhouding op 11.6% brengt. De totale activa en totale passiva bedragen respectievelijk CN¥4.3B en CN¥818.1M. De EBIT Boai NKY Medical Holdings is CN¥430.6M waardoor de rentedekking -54.3 is. Het heeft contanten en kortetermijnbeleggingen van CN¥322.0M.

Belangrijke informatie

11.6%

Verhouding schuld/eigen vermogen

CN¥405.39m

Schuld

Rente dekkingsratio	-54.3x
Contant	CN¥322.01m
Aandelen	CN¥3.49b
Totaal verplichtingen	CN¥818.11m
Totaal activa	CN¥4.30b

Recente financiële gezondheidsupdates

Does Boai NKY Medical Holdings (SZSE:300109) Have A Healthy Balance Sheet?

Jul 25

Recent updates

We Think That There Are More Issues For Boai NKY Medical Holdings (SZSE:300109) Than Just Sluggish Earnings

Oct 31

Market Might Still Lack Some Conviction On Boai NKY Medical Holdings Ltd. (SZSE:300109) Even After 40% Share Price Boost

Oct 08

Boai NKY Medical Holdings Ltd. (SZSE:300109) Doing What It Can To Lift Shares

Aug 23

Does Boai NKY Medical Holdings (SZSE:300109) Have A Healthy Balance Sheet?

Jul 25

Boai NKY Medical Holdings (SZSE:300109) Is Paying Out A Larger Dividend Than Last Year

Jun 04

We Like These Underlying Return On Capital Trends At Boai NKY Medical Holdings (SZSE:300109)

May 27

Should You Be Adding Boai NKY Medical Holdings (SZSE:300109) To Your Watchlist Today?

Apr 03

Boai NKY Medical Holdings Ltd. (SZSE:300109) Stock Rockets 39% But Many Are Still Ignoring The Company

Mar 04

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( CN¥1.3B ) 300109 } overtreffen de korte termijn passiva ( CN¥613.4M ).

Langlopende schulden: De kortetermijnactiva 300109 ( CN¥1.3B ) overtreffen de langetermijnschulden ( CN¥204.7M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 2.4% ) 300109 wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van 300109 is de afgelopen 5 jaar gedaald van 27.4% naar 11.6%.

Schuldendekking: De schuld van 300109 wordt goed gedekt door de operationele kasstroom ( 105.3% ).

Rentedekking: 300109 verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.

Boai NKY Medical Holdings Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Does Boai NKY Medical Holdings (SZSE:300109) Have A Healthy Balance Sheet?

Recent updates

We Think That There Are More Issues For Boai NKY Medical Holdings (SZSE:300109) Than Just Sluggish Earnings

New minor risk - Shareholder dilution

Third quarter 2024 earnings released: EPS: CN¥0.21 (vs CN¥0.30 in 3Q 2023)

Investor sentiment deteriorates as stock falls 20%

Market Might Still Lack Some Conviction On Boai NKY Medical Holdings Ltd. (SZSE:300109) Even After 40% Share Price Boost

Boai NKY Medical Holdings Ltd. to Report Q3, 2024 Results on Oct 23, 2024

Investor sentiment improves as stock rises 22%

Now 26% overvalued

Second quarter 2024 earnings released: EPS: CN¥0.20 (vs CN¥0.29 in 2Q 2023)

Boai NKY Medical Holdings Ltd. (SZSE:300109) Doing What It Can To Lift Shares

Does Boai NKY Medical Holdings (SZSE:300109) Have A Healthy Balance Sheet?

Boai NKY Medical Holdings Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Boai NKY Medical Holdings (SZSE:300109) Is Paying Out A Larger Dividend Than Last Year

Dividend increased to CN¥1.00

Boai NKY Medical Holdings Ltd. Announces Implementation of Final A Share Cash Dividend for 2023, Payable on 07 June 2024

We Like These Underlying Return On Capital Trends At Boai NKY Medical Holdings (SZSE:300109)

Boai NKY Medical Holdings Ltd. Approves Cash Dividend for the Year 2023

Boai NKY Medical Holdings Ltd., Annual General Meeting, May 23, 2024

First quarter 2024 earnings released: EPS: CN¥0.38 (vs CN¥0.39 in 1Q 2023)

Boai NKY Medical Holdings Ltd. Proposes Final Cash Dividend for 2023

Should You Be Adding Boai NKY Medical Holdings (SZSE:300109) To Your Watchlist Today?

Now 23% overvalued after recent price rise

Boai NKY Medical Holdings Ltd. to Report Q1, 2024 Results on Apr 27, 2024

Boai NKY Medical Holdings Ltd. (SZSE:300109) Stock Rockets 39% But Many Are Still Ignoring The Company

Full year 2023 earnings released: EPS: CN¥1.63 (vs CN¥0.88 in FY 2022)

Boai NKY Medical Holdings Ltd. announced that it expects to receive CNY 623 million in funding

Boai NKY Medical Holdings Ltd. announced that it expects to receive CNY 623 million in funding

Investor sentiment deteriorates as stock falls 20%

Boai NKY Medical Holdings Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024

Third quarter 2023 earnings released: EPS: CN¥0.45 (vs CN¥0.42 in 3Q 2022)

Boai NKY Medical Holdings Ltd. to Report Q3, 2023 Results on Oct 25, 2023

Second quarter 2023 earnings released: EPS: CN¥0.44 (vs CN¥0.34 in 2Q 2022)

Boai NKY Medical Holdings Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on May 30, 2023

Boai NKY Medical Holdings Ltd. Approves Cash Dividend for 2022

First quarter 2023 earnings released: EPS: CN¥0.39 (vs CN¥0.10 in 1Q 2022)

Full year 2022 earnings released: EPS: CN¥0.96 (vs CN¥0.91 in FY 2021)

Investor sentiment deteriorated over the past week

High number of new directors

Third quarter 2022 earnings released: EPS: CN¥0.42 (vs CN¥0.046 in 3Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Gryningskust Holding AB acquired additional 14.0 % minority stake in NeoDynamics AB (publ) (OM:NEOD).

Boai NKY Medical Holdings Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on 30 May 2022

Boai NKY Medical Holdings Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on 30 May 2022

Boai Nky Medical Holdings Ltd. Approves Cash Dividend

Boai NKY Medical Holdings Ltd. Proposes Final Cash Dividend for the Year 2021

First quarter 2022 earnings: EPS and revenues miss analyst expectations

High number of new and inexperienced directors

Investor sentiment deteriorated over the past week

Full year 2021 earnings: EPS and revenues miss analyst expectations

Boai NKY Medical Holdings Ltd. (SZSE:300109) commences a Equity Buyback Plan under the authorization approved on December 21, 2021.

Third quarter 2021 earnings released: EPS CN¥0.046 (vs CN¥0.08 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.067 (vs CN¥0.12 in 2Q 2020)

Abcam plc (AIM:ABC) entered into a definitive agreement to acquire BioVision, Inc. from Boai NKY Medical Holdings Ltd. (SZSE:300109) for approximately $340 million.

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Shanghai Haitong Securities Assets Management Co.,Ltd. completed the acquisition of 3% stake in Boai NKY Medical Holdings Ltd. (SZSE:300109) from Wang Donghu.

Boai Nky Medical Holdings Ltd. Approves Final Cash Dividend for 2020

Boai NKY Medical Holdings Ltd. Proposes Final Cash Dividend for 2020

First quarter 2021 earnings released: EPS CN¥0.19 (vs CN¥0.04 in 1Q 2020)

Investor sentiment deteriorated over the past week

New 90-day low: CN¥11.20

New 90-day low: CN¥11.89

Ningbo Tianlong Electronics Co., Ltd. (SHSE:603266) entered into a equity transfer agreement to acquire 4.1818% stake in Wuhan First Bioscience Inc. from Boai NKY Medical Holdings Ltd. (SZSE:300109) for CNY 14 million.

New 90-day low: CN¥13.80

New 90-day low: CN¥15.06

New 90-day low: CN¥16.55

Third quarter earnings released

Market bids up stock over the past week

New 90-day high: CN¥19.40

New 90-day high: CN¥19.24

Fang Huasheng and Ren Dalong acquired 18.99% stake in Boai NKY Pharmaceuticals Ltd. (SZSE:300109).

New 90-day high - CN¥18.63

Earnings released